Projected Income Statement: CCL Products (India) Limited

Forecast Balance Sheet: CCL Products (India) Limited

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 - - 8,327 14,510 17,149 14,051 11,173 8,502
Change - - - 74.25% 18.19% -18.06% -20.48% -23.91%
Announcement Date 21/05/21 26/05/22 16/05/23 12/05/24 05/05/25 - - -
1INR in Million
Estimates

Cash Flow Forecast: CCL Products (India) Limited

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 1,546 1,899 3,323 5,133 4,180 666.2 881.9 1,250
Change - 22.84% 74.94% 54.48% -18.57% -84.06% 32.38% 41.74%
Free Cash Flow (FCF) 1 162.2 -891.9 -1,339 -4,579 -1,283 5,325 5,327 4,306
Change - -649.9% -50.17% -241.87% 71.99% 515.14% 0.04% -19.17%
Announcement Date 21/05/21 26/05/22 16/05/23 12/05/24 05/05/25 - - -
1INR in Million
Estimates

Forecast Financial Ratios: CCL Products (India) Limited

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 23.96% 22.64% 19.31% 16.78% 17.87% 16.96% 17.66% 17.85%
EBIT Margin (%) 19.99% 18.71% 16.23% 13.1% 14.7% 13.5% 14.42% 14.7%
EBT Margin (%) 18.9% 17.87% 14.73% 10.41% 11.34% 10.68% 12.38% 13.26%
Net margin (%) 14.67% 13.98% 12.98% 9.42% 9.99% 8.91% 10.4% 11.25%
FCF margin (%) 1.31% -6.1% -6.47% -17.25% -4.13% 12.95% 11.56% 8.1%
FCF / Net Income (%) 8.9% -43.65% -49.81% -183.1% -41.33% 145.38% 111.21% 71.97%

Profitability

        
ROA - - - - - - - -
ROE 18.08% 17.48% 19.68% 15.77% 17.05% 17.36% 20.17% 21.3%

Financial Health

        
Leverage (Debt/EBITDA) - - 2.08x 3.26x 3.09x 2.02x 1.37x 0.9x
Debt / Free cash flow - - -6.22x -3.17x -13.37x 2.64x 2.1x 1.97x

Capital Intensity

        
CAPEX / Current Assets (%) 12.44% 12.99% 16.04% 19.34% 13.46% 1.62% 1.91% 2.35%
CAPEX / EBITDA (%) 51.93% 57.37% 83.1% 115.26% 75.29% 9.55% 10.84% 13.16%
CAPEX / FCF (%) 953.28% -212.95% -248.07% -112.09% -325.86% 12.51% 16.55% 29.03%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 4 5 5.5 4.5 5 6.817 8.233 9.42
Change - 25% 10% -18.18% 11.11% 36.33% 20.78% 14.41%
Book Value Per Share 1 81.73 94.02 111.4 125.8 147.7 168 196.8 228.4
Change - 15.03% 18.51% 12.93% 17.4% 13.76% 17.09% 16.1%
EPS 1 13.7 15.36 20.21 18.7 23.26 27.46 35.28 43.7
Change - 12.12% 31.58% -7.47% 24.39% 18.04% 28.51% 23.86%
Nbr of stocks (in thousands) 1,33,028 1,33,028 1,33,028 1,33,528 1,33,528 1,33,528 1,33,528 1,33,528
Announcement Date 21/05/21 26/05/22 16/05/23 12/05/24 05/05/25 - - -
1INR
Estimates
2026 *2027 *
P/E ratio 35.9x 28x
PBR 5.87x 5.01x
EV / Sales 3.55x 3.1x
Yield 0.69% 0.83%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
-
Quality
-
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
986.50INR
Average target price
1,070.50INR
Spread / Average Target
+8.51%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CCL Stock
  4. CCL Stock
  5. Financials CCL Products (India) Limited